Latest News
23.02.2010
Meet Antitope at BIO Europe 2010 (Barcelona, Spain 8th - 10th March)
Antitope will be participating in the Business Partnering Forum at the BIO International Convention and welcome the opportunity to discuss potential collaborations with companies that are interested in assessing and/or removing immunogenicity from protein therapeutics. Meetings can be arranged...
Meet Antitope at BIO Europe 2010 (Barcelona, Spain 8th - 10th March)
Antitope will be participating in the Business Partnering Forum at the BIO International Convention and welcome the opportunity to discuss potential collaborations with companies that are interested in assessing and/or removing immunogenicity from protein therapeutics. Meetings can be arranged...
26.01.2010
Antitope Ltd. today announced a research agreement with Agence Nationale de Recherches sur le SIDA et les hepatitives virales (ANRS, France), INSERM (France) and Baylor Research Institute (BRI, Dallas, Texas USA)
Cambridge UK, January 2010 - Antitope Ltd. today announced a research agreement with Agence Nationale de Recherches sur le SIDA et les hepatitives virales (ANRS, France), INSERM (France) and Baylor Research Institute (BRI, Dallas, Texas USA) for the generation of multiple humanized antibodies....
Antitope Ltd. today announced a research agreement with Agence Nationale de Recherches sur le SIDA et les hepatitives virales (ANRS, France), INSERM (France) and Baylor Research Institute (BRI, Dallas, Texas USA)
Cambridge UK, January 2010 - Antitope Ltd. today announced a research agreement with Agence Nationale de Recherches sur le SIDA et les hepatitives virales (ANRS, France), INSERM (France) and Baylor Research Institute (BRI, Dallas, Texas USA) for the generation of multiple humanized antibodies....
26.01.2010
Antitope Announces Research Agreement with Emory University
26th January 2010 - Antitope Ltd. (UK) today announced a research agreement with Emory University, Atlanta (USA) for the development of an antibody therapeutic for H1N1 influenza (‘swine flu’) generated through a collaboration between researchers at Emory University and the University...
Antitope Announces Research Agreement with Emory University
26th January 2010 - Antitope Ltd. (UK) today announced a research agreement with Emory University, Atlanta (USA) for the development of an antibody therapeutic for H1N1 influenza (‘swine flu’) generated through a collaboration between researchers at Emory University and the University...
